Blood thinner choice after a stroke while on a DOAC
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial compares two types of blood thinners (DOACs like apixaban or rivaroxaban, and warfarin) to see which works better for people who have a stroke while taking a DOAC. The goal is to find the safest and most effective option to prevent another stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke while taking a DOAC blood thinner within the last 14 days.
- You have atrial fibrillation (AF) or atrial flutter (a type of irregular heartbeat).
- You are able to start a blood thinner again within 24 hours of joining the study.
- You have not had a bleeding stroke in the past.
- You are not on chronic dialysis or expected to need it soon.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether patients with atrial fibrillation (a heart rhythm disorder) who have had both a previous brain bleed and a recent stroke can safely take blood thinners to prevent future strokes. Researchers want to find the safest approach for people in this high-risk situation.
This study compares two blood-thinning medicines, edoxaban and apixaban, to see which one is better at preventing strokes and bleeding in people who have both atrial fibrillation and coronary artery disease. If you're eligible, you may receive one of these standard treatments, and the trial could help find the safer option.
This study looks at people who had a stroke while taking blood thinners (anticoagulants) for an irregular heartbeat. It aims to learn more about these strokes and how to better prevent them in the future.
This study is testing a new scoring system to predict stroke risk in people with atrial fibrillation who are taking DOAC blood thinners. The goal is to help doctors personalize treatment and prevent blood clots.
This trial tests whether giving a clot-dissolving medicine (alteplase or tenecteplase) is safe and effective for people who have had a stroke and are taking a blood thinner (DOAC) like apixaban or rivaroxaban. It aims to see if this treatment can still be given within a few hours of the stroke.
This study compares two types of blood-thinning medicines to see which one is better at preventing another stroke in people who had a stroke without a clear cause. It may help if you had a stroke recently and have certain heart-related risk factors.
Hear when a new Stroke (in Patients With Atrial Fibrillation) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.